Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

Item
http://www.wikidata.org/entity/Q35214578
Patient-Reported Outcomes in Oncology Drug Labeling in the United States: A Framework for Navigating Early Challenges.Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project†.Robot-assisted resection of gastrointestinal stromal tumors (GIST): a single center case series and literature review.Identification of clinical biomarkers for patients with advanced hepatocellular carcinoma receiving sorafenib.Health-related quality-of-life as co-primary endpoint in randomized clinical trials in oncology.Presentation and outcome of frequent and rare sarcoma histologic subtypes: A study of 10,262 patients with localized visceral/soft tissue sarcoma managed in reference centers.Lessons from three phase III trials assessing neoadjuvant treatment in sarcoma patients.Searching for aurora in the night of sarcoma phase II trials: isn't it time to move to second gear?Surrogate endpoints in advanced sarcoma trials: a meta-analysis
P2860

Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

Item
http://www.wikidata.org/entity/Q35214578
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Guidelines for time-to-event e ...... Endpoints in CANcer trials)†.
@ast
Guidelines for time-to-event e ...... Endpoints in CANcer trials)†.
@en
type
label
Guidelines for time-to-event e ...... Endpoints in CANcer trials)†.
@ast
Guidelines for time-to-event e ...... Endpoints in CANcer trials)†.
@en
prefLabel
Guidelines for time-to-event e ...... Endpoints in CANcer trials)†.
@ast
Guidelines for time-to-event e ...... Endpoints in CANcer trials)†.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Guidelines for time-to-event e ...... t Endpoints in CANcer trials)†
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698